S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
Why Your IRA Could Crash on January 16th? (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
Why Your IRA Could Crash on January 16th? (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal
Why Your IRA Could Crash on January 16th? (Ad)
Rail workers say deal won't resolve quality-of-life concerns
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
Why Your IRA Could Crash on January 16th? (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
Why Your IRA Could Crash on January 16th? (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal
Why Your IRA Could Crash on January 16th? (Ad)
Rail workers say deal won't resolve quality-of-life concerns
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
Why Your IRA Could Crash on January 16th? (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
Why Your IRA Could Crash on January 16th? (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal
Why Your IRA Could Crash on January 16th? (Ad)
Rail workers say deal won't resolve quality-of-life concerns
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
Why Your IRA Could Crash on January 16th? (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Why CSL Ltd Stock Could Be Worth a Look
Why Your IRA Could Crash on January 16th? (Ad)
MarketBeat: Week in Review 11/28 – 12/02
Estonia to buy US rocket artillery system in $200M deal
Why Your IRA Could Crash on January 16th? (Ad)
Rail workers say deal won't resolve quality-of-life concerns
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
NASDAQ:AVGR

Avinger - AVGR Stock Forecast, Price & News

$1.25
-0.01 (-0.79%)
(As of 12/2/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.22
$1.28
50-Day Range
$0.96
$1.30
52-Week Range
$0.94
$11.99
Volume
47,707 shs
Average Volume
51,715 shs
Market Capitalization
$9.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

Avinger MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
620.0% Upside
$9.00 Price Target
Short Interest
Healthy
1.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.99 out of 5 stars

AVGR stock logo

About Avinger (NASDAQ:AVGR) Stock

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.

Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

AVGR Stock News Headlines

Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com
StockNews.com Initiates Coverage on Avinger (NASDAQ:AVGR)
Avinger Reports Third Quarter 2022 Results
Avinger to Present at LD Micro Investor Conference
Avinger, Inc. (AVGR)
Avinger Reports Second Quarter 2022 Results
Avinger stock slides on ~$5M securities offering
See More Headlines
Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

AVGR Company Calendar

Last Earnings
11/11/2021
Today
12/03/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/28/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AVGR
Employees
68
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.00
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+620.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-17,410,000.00
Net Margins
-212.53%
Pretax Margin
-212.53%

Debt

Sales & Book Value

Annual Sales
$10.13 million
Book Value
$0.67 per share

Miscellaneous

Free Float
7,400,000
Market Cap
$9.30 million
Optionable
Not Optionable
Beta
1.61

Key Executives

  • Mr. Jeffrey M. Soinski (Age 60)
    Pres, CEO & Director
    Comp: $594.82k
  • Mr. Himanshu N. Patel (Age 62)
    Chief Technology Officer
    Comp: $416.05k
  • Mr. Nabeel Subainati (Age 39)
    VP, Controller, Principal Financial Officer & Accounting Officer
  • Mr. Keith Schaefer
    Chief Operating Officer













AVGR Stock - Frequently Asked Questions

Should I buy or sell Avinger stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AVGR shares.
View AVGR analyst ratings
or view top-rated stocks.

What is Avinger's stock price forecast for 2023?

1 Wall Street research analysts have issued 1 year price targets for Avinger's shares. Their AVGR share price forecasts range from $9.00 to $9.00. On average, they anticipate the company's share price to reach $9.00 in the next year. This suggests a possible upside of 620.0% from the stock's current price.
View analysts price targets for AVGR
or view top-rated stocks among Wall Street analysts.

How have AVGR shares performed in 2022?

Avinger's stock was trading at $9.00 at the start of the year. Since then, AVGR shares have decreased by 86.1% and is now trading at $1.25.
View the best growth stocks for 2022 here
.

When is Avinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 28th 2023.
View our AVGR earnings forecast
.

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) released its quarterly earnings results on Thursday, November, 11th. The medical device company reported ($1.20) earnings per share for the quarter, topping the consensus estimate of ($1.40) by $0.20. The medical device company had revenue of $2.37 million for the quarter, compared to the consensus estimate of $2.52 million. Avinger had a negative trailing twelve-month return on equity of 244.04% and a negative net margin of 212.53%. During the same period last year, the business earned ($1.60) earnings per share.

When did Avinger's stock split?

Shares of Avinger reverse split on the morning of Tuesday, March 15th 2022. The 1-20 reverse split was announced on Tuesday, March 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, March 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Avinger own?
When did Avinger IPO?

(AVGR) raised $60 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

Who are Avinger's major shareholders?

Avinger's stock is owned by many different institutional and retail investors. Top institutional investors include Armistice Capital LLC (8.99%), Vanguard Group Inc. (1.85%) and Perkins Capital Management Inc. (0.67%). Insiders that own company stock include Himanshu Patel, James Cullen, Jeffrey M Soinski and Mark Weinswig.
View institutional ownership trends
.

How do I buy shares of Avinger?

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $1.25.

How much money does Avinger make?

Avinger (NASDAQ:AVGR) has a market capitalization of $9.30 million and generates $10.13 million in revenue each year. The medical device company earns $-17,410,000.00 in net income (profit) each year or ($5.30) on an earnings per share basis.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The official website for the company is www.avinger.com. The medical device company can be reached via phone at (650) 241-7900, via email at info@dawson3d.com, or via fax at 800-229-2696.

This page (NASDAQ:AVGR) was last updated on 12/3/2022 by MarketBeat.com Staff